-transparent.png){kind=logo}
beta-N-Acetyl-D-glucosaminidase and its kinetic characteristics were determined in serum and skin from both diabetes mellitus and impaired glucose tolerance patients and controls. Mean total activity was reduced (p less than 0.05) in the skin of both patient groups. beta-N-Acetyl-D-glucosaminidase isoenzyme expression was investigated using chromatofocusing on PBE-94 coupled with automated enzyme assay. The isoenzyme profiles from serum showed two major forms (A and B) whose ratio varied from 2:1 in controls to 3:1 in diabetics. Moreover, diabetes mellitus and impaired glucose tolerance subjects displayed an intermediate (I) form. The A/B isoenzyme ratio was completely reversed in skin.
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
February 1992,
Clinical chemistry,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
September 1986,
Clinica chimica acta; international journal of clinical chemistry,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
July 1988,
Minerva medica,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
December 1988,
Clinical chemistry,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
July 1998,
Biochemistry and molecular biology international,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
January 1976,
Human genetics,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
December 1979,
Clinical endocrinology,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
March 1992,
JPMA. The Journal of the Pakistan Medical Association,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
May 1995,
Nihon rinsho. Japanese journal of clinical medicine,
A Orlacchio, and
C Maffei, and
T Beccari, and
P Lisi
January 1998,
Nihon rinsho. Japanese journal of clinical medicine,
